Related Experiment Videos
New dsDNA binding unnatural oligopeptides with pyrimidine selectivity
Zhenyu Zhang1, Patrick Chaltin, Arthur Van Aerschot
1Laboratory of Medicinal Chemistry, Rega Institute for Medical Research, Katholieke Universiteit Leuven, Minderbroedersstraat 10, Leuven, Belgium.
Bioorganic & Medicinal Chemistry
|September 6, 2002
Summary
Researchers developed novel unnatural peptides and hybrid molecules for sequence-specific double-stranded DNA (dsDNA) binding. Modifications significantly enhanced binding affinity and selectivity, offering new tools for DNA-targeted applications.
Area of Science:
- Medicinal Chemistry
- Molecular Biology
- Biotechnology
Background:
- Developing sequence-specific DNA-binding molecules is crucial for therapeutic and diagnostic applications.
- Peptide-based ligands offer a versatile scaffold for DNA recognition.
Purpose of the Study:
- To investigate the contribution of amino acid side chains to peptide-dsDNA binding affinity.
- To optimize a lead DNA-binding peptide through unnatural amino acid substitution and hybrid molecule design.
- To develop novel sequence-specific dsDNA binding ligands.
Main Methods:
- Solid and solution phase peptide library screening.
- Ethidium bromide displacement assay to assess dsDNA binding affinity.
- Deconvolution and optimization using unnatural amino acids (Cbg, Cha).
- Hybrid molecule formation with an acridine derivative.
- DNase I footprinting for sequence specificity analysis.
Main Results:
- Identified a lead peptide with dsDNA binding capability.
- Optimized peptide sequence using unnatural amino acids (Cbg, Cha) yielded a 10-fold increase in affinity.
- Hybrid molecules achieved microM range affinities (K(d) of 2.1 x 10(-6) M).
- DNase I footprinting revealed pyrimidine specificity for oligopeptides, shifting to mixed sequences with intercalator conjugation.
Conclusions:
- Unnatural peptide library approach is effective for discovering novel dsDNA binding ligands.
- Systematic modification of peptide structure allows fine-tuning of DNA binding affinity and sequence selectivity.
- Developed novel unnatural oligopeptides and hybrid molecules with tailored DNA recognition properties.